Procter & Gamble (NYSE: PG) insider transactions
In the twelve months to 10 November 2026, executives and directors of Procter & Gamble reported 39 open-market sales of 583,205 shares ($93.1m) and 0 open-market purchases, by 15 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 5 November 2026 | Santos de Azevedo Juliana Monteiro | CEO - Grooming | Open-market sale | −5,370 | $169.00 | 21,361 | Form 4 |
| 5 November 2026 | Schulten Andre | Chief Financial Officer | Option exercise | +30,677 | $78.52 | 96,295 | Form 4 |
| 5 November 2026 | Schulten Andre | Chief Financial Officer | Open-market sale | −30,677 | $169.00 | 65,618 | Form 4 |
| 4 November 2026 | Schulten Andre | Chief Financial Officer | Option exercise | +33,624 | $91.07 | 99,242 | Form 4 |
| 4 November 2026 | Schulten Andre | Chief Financial Officer | Open-market sale | −33,624 | $165.00 | 65,618 | Form 4 |
| 3 November 2026 | Janzaruk Matthew W. | SVP - Chief Accounting Officer | Option exercise | +9,479 | $98.55 | 10,750 | Form 4 |
| 3 November 2026 | Janzaruk Matthew W. | SVP - Chief Accounting Officer | Open-market sale | −9,479 | $163.00 | 1,271 | Form 4 |
| 30 October 2026 | Raman Sundar G. | CEO-Fabric Home & Habitat Care | Option exercise | +38,253 | $98.55 | 85,998 | Form 4 |
| 30 October 2026 | Raman Sundar G. | CEO-Fabric Home & Habitat Care | Open-market sale | −38,253 | $165.00 | 47,745 | Form 4 |
| 30 October 2026 | Aguilar Moses Victor Javier | Chf Rsch, Dev & Innov Officer | Option exercise | +18,812 | $78.52 | 74,055 | Form 4 |
| 30 October 2026 | Aguilar Moses Victor Javier | Chf Rsch, Dev & Innov Officer | Open-market sale | −18,812 | $164.43 | 55,243 | Form 4 |
| 30 October 2026 | Gama Paul | CEO- Health Care | Open-market sale | −2,894 | $165.00 | 43,899 | Form 4 |
| 23 October 2026 | Gama Paul | CEO- Health Care | Open-market sale | −4,331 | $161.27 | 46,793 | Form 4 |
| 23 October 2026 | Purushothaman Balaji | Chief Human Resources Officer | Open-market sale | −4,181 | $160.71 | 11,296 | Form 4 |
| 23 October 2026 | Jejurikar Shailesh | Chairman, President and CEO | Option exercise | +35,000 | $78.52 | 90,391 | Form 4 |
| 23 October 2026 | Jejurikar Shailesh | Chairman, President and CEO | Open-market sale | −35,000 | $163.09 | 55,391 | Form 4 |
| 13 October 2026 | Allen Bertrand Marc | Director | Grant or award | +1,438 | — | 12,698 | Form 4 |
| 13 October 2026 | Arnold Craig | Director | Grant or award | +1,438 | — | 4,474 | Form 4 |
| 13 October 2026 | Biggs M. Brett | Director | Grant or award | +1,438 | — | 6,900 | Form 4 |
| 13 October 2026 | Bonini Sheila | Director | Grant or award | +1,438 | — | 5,983 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Procter & Gamble page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.